Mediwelcome Healthcare Management & Technology Inc.

Mediwelcome Healthcare Management & Technology Inc.

2159.HK
Mediwelcome Healthcare Management & Technology Inc.HK flagHong Kong Stock Exchange
1.67
HKD
+0.02
- -
453.31MMarket Cap
Mediwelcome Healthcare Management & Technology Inc.
2159.HK
(Hong Kong Stock Exchange)

Recent

price

1.66

P/E

ratio

- -

div

yld

- -

ROIC.AI

2017
2018
2019
2020
2021
2022
2023
2024
FRC
1.29
1.49
2.14
2.16
3.91
1.74
1.73
1.68
Revenue per Share
0.15
0.19
0.1
0.11
0.03
-0.48
-0.49
-0.24
Basic EPS, GAAP
-0.03
0.27
-0.04
0.09
-0.14
-0.12
-0.4
-0.14
Free Cash Flow per Basic Share
- -
0.07
- -
- -
- -
- -
- -
- -
Dividend per Share
0.07
0.27
- -
- -
0.39
-0.05
-0.54
-0.77
Book Value per Share
0.49
0.61
0.6
0.72
1.39
0.92
0.63
0.38
Tangible Book Value per Share
200
200
200
200
181
186
191
191
Basic Weighted Avg Shares
259
299
427
432
708
323
331
322
Sales/Revenue/Turnover
15.26
16.6
7.34
5.32
-0.28
-28.14
-22.01
-8.09
Operating Margin (%)
8
8
11
18
19
21
21
10
Depreciation Expense
30
38
21
21
5
-89
-94
-45
Net Income, GAAP
20.73
19.28
15.07
1.36
6.91
- -
- -
- -
Effective Tax Rate (%)
11.46
12.72
4.88
4.87
0.66
-27.58
-28.4
-14.07
Profit Margin (%)
88
69
96
117
218
143
89
44
Working Capital
1
3
- -
23
16
8
2
4
LT Debt
99
127
145
171
293
201
120
73
Total Equity
- -
31.89
18.03
13.1
-0.71
- -
- -
- -
Return on Invested Capital (%)
- -
80.13
47.97
86.91
7.44
- -
- -
- -
Return on Capital (%)
- -
111.94
76.92
2,104,200
13.17
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-4.21%
-38.92%
Free Cash Flow
- -
-76.12%
-64.88%
Net Income, GAAP
- -
-428.77%
-51.92%
Sales/Revenue/Turnover
- -
2.04%
-2.94%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
331
2024
- -
- -
- -
- -
322
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-0.49
2024
- -
- -
- -
- -
-0.24
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Business
Mediwelcome Healthcare Management & Technology Inc. (2159.HK), an investment holding company incorporated in the Cayman Islands, provides integrated healthcare marketing solutions primarily in the People's Republic of China. The company offers an academic conference management system for digital medical conference management; scientific data reporting system for single-disease clinical research data collection; health education media including a health science cloud platform, patient care center, patient management center, and health education media; medical conference services; patient education and screening services; marketing strategy and consulting services; digital marketing and sales solutions services; contract research organization services comprising patient recruitment and clinical data collection; internet hospital services via mobile applications such as Mediwelcome Doctor+ and Doctor+ for Doctor providing online follow-up consultations and e-prescriptions; digital therapy services; science research and development services; and IT and software services to pharmaceutical companies, medical associations, medical institutions, foundations, and patients. Founded in 2000 and headquartered at 17th Floor, Tower 7, Parkview Place, 2 East 4th Ring Road, Chaoyang District, Beijing, the company operates principally in China with platforms like Giraffe Smart Medical Platform, Medical Camp Platform, and Giraffe Doctor+ Internet Hospital Platform. In recent developments, the company advanced AIGC technology applications enhancing platform functionalities and launched a web 3.0-based digital asset management platform in June 2024 to assist doctors in managing and trading medical content copyrights; completed a share placement raising HK$21.3 million between June and July 2025 for general working capital to support business expansion; and reported interim revenue of RMB127.1 million for the six months ended 30 June 2025, with growth in marketing strategy and consulting services (RMB66.6 million) and digital marketing and sales solutions (RMB14.1 million), alongside registered doctor users reaching 781,606 on its digital medical platform and 56,154 on its internet medical platform.